Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Barton

Showing results (11-20 of 129) with videos related to

Pageof 13
Sort By:
Cancer|March 17, 2004
Estimation of an optimal radiotherapy utilization rate for melanoma: a review of the evidenceGeoff Delaney, Michael Barton, Susannah Jacob
Cancer|December 22, 2004
Estimating the optimal external-beam radiotherapy utilization rate for genitourinary malignanciesGeoff Delaney, Susannah Jacob, Michael Barton
Cancer|December 16, 2005
Estimating the optimal radiotherapy utilization for carcinoma of the central nervous system, thyroid carcinoma, and carcinoma of unknown primary origin from evidence-based clinical guidelinesGeoff Delaney, Susannah Jacob, Michael Barton
Cureus|March 21, 2023
Racial Equity in Healthcare Machine Learning: Illustrating Bias in Models With Minimal Bias MitigationMichael Barton, Mahmoud Hamza, Borna Guevel
Cancer|August 12, 2004
Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part I--malignancies of the cervix, ovary, vagina and vulvaGeoff Delaney, Susannah Jacob, Michael Barton
Computer Aided Design|August 25, 2020
SPM 2020 EditorialXin Li, Michael Barton, Saigopal Nelaturi
New South Wales Public Health Bulletin|July 10, 2002
Area Cancer Control Network: From cottage industry to strategic careKatherine Tynan, Michael Barton, William Kricker
Cancer|April 28, 2005
Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinomaGeoff Delaney, Susannah Jacob, Michael Barton
Plos One|November 20, 2018
Evaluating gentrification's relation to neighborhood and city healthJoseph Gibbons, Michael Barton, Elizabeth Brault
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 6, 2005
The contribution of cytotoxic chemotherapy to 5-year survival in adult malignanciesGraeme Morgan, Robyn Ward, Michael Barton
Pageof 13

Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
Cancer|March 17, 2004
Estimation of an optimal radiotherapy utilization rate for melanoma: a review of the evidenceGeoff Delaney, Michael Barton, Susannah Jacob
Cancer|December 22, 2004
Estimating the optimal external-beam radiotherapy utilization rate for genitourinary malignanciesGeoff Delaney, Susannah Jacob, Michael Barton
Cancer|December 16, 2005
Estimating the optimal radiotherapy utilization for carcinoma of the central nervous system, thyroid carcinoma, and carcinoma of unknown primary origin from evidence-based clinical guidelinesGeoff Delaney, Susannah Jacob, Michael Barton
Cureus|March 21, 2023
Racial Equity in Healthcare Machine Learning: Illustrating Bias in Models With Minimal Bias MitigationMichael Barton, Mahmoud Hamza, Borna Guevel
Cancer|August 12, 2004
Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part I--malignancies of the cervix, ovary, vagina and vulvaGeoff Delaney, Susannah Jacob, Michael Barton
Computer Aided Design|August 25, 2020
SPM 2020 EditorialXin Li, Michael Barton, Saigopal Nelaturi
New South Wales Public Health Bulletin|July 10, 2002
Area Cancer Control Network: From cottage industry to strategic careKatherine Tynan, Michael Barton, William Kricker
Cancer|April 28, 2005
Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinomaGeoff Delaney, Susannah Jacob, Michael Barton
Plos One|November 20, 2018
Evaluating gentrification's relation to neighborhood and city healthJoseph Gibbons, Michael Barton, Elizabeth Brault
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 6, 2005
The contribution of cytotoxic chemotherapy to 5-year survival in adult malignanciesGraeme Morgan, Robyn Ward, Michael Barton
Pageof 13